While I applaud the descriptions used by Eccles and Davies to describe various approaches to chronic pain patient management as embraced by different doctors (particularly that used by Dr B), it seems to me that they then proceed further along the biomedical route by exploring hypermobility syndromes, small fibre neuropathy, mast cell activation disorders and inflammatory reactivity. This approach, in my experience, further entrenches ‘illness behaviour’ and distress among patients with functional chronic pain conditions and fails to approach pain management through a biopsychosocial approach. This then becomes a ‘barrier to progress’.
8
The impact of psychological illness on chronic pain symptom presentation is well recognised and a holistic approach to managing these patients through illness de-escalation and promoting improved self efficacy is, in my opinion, more appropriate.